(3-(4-chlorophenyl)-4-cyano-5-(isopropylthio)thiophen-2-yl)methyl acetate | 1191249-26-9

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: (3-(4-chlorophenyl)-4-cyano-5-(isopropylthio)thiophen-2-yl)methyl acetate
• 英文别名: [3-(4-Chlorophenyl)-4-cyano-5-propan-2-ylsulfanylthiophen-2-yl]methyl acetate
• CAS: 1191249-26-9
• 化学式: C₁₇H₁₆ClNO₂S₂
• 分子量: 365.905
• InChiKey: VPABECBULDFRDG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  104
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4-(4-chlorophenyl)-5-(hydroxymethyl)-2-(isopropylthio)thiophene-3-carbonitrile 、 乙酸酐 在 4-二甲氨基吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 36.0h， 以76%的产率得到(3-(4-chlorophenyl)-4-cyano-5-(isopropylthio)thiophen-2-yl)methyl acetate
  参考文献：
  名称：

  在芳基噻吩系列中发现一类新型的蛋白质法呢基转移酶抑制剂

  摘要：

  ICSN化学文库的筛选导致发现3-（4-氯苯基）-4-氰基-5-硫代烷基噻吩2-羧酸作为有效的法呢基转移酶抑制剂。酶动力学研究表明，该原始FTI系列属于CaaX竞争性抑制剂类别。SAR的初步研究使我们能够将IC 50从110 nM提高到7.5 nM。

  DOI：

  10.1021/jm901280q

文献信息

• [EN] INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS<br/>[FR] INHIBITION DE VOIES DE BIOSYNTHÈSE D'ISOPRÉNOÏDES POUR TRAITER DES TROUBLES AUTO-IMMUNS
  申请人：TABACZYNSKI DAVID A

  公开号：WO2015084721A1

  公开（公告）日：2015-06-11

  The invention provides methods and pharmaceutical compositions that can treat autoimmune disease by reducing the production of pyrophosphate intermediates produced during the biosynthesis of isoprenoids. The pyrophosphate compounds being inhibited are normally produced through the mevalonate and non-mevalonate pathways of the host vertebrate organisms and their symbiotic and pathogenic microorganisms. The methods involve administering to a patient an inhibitor of the mevalonate-dependent pathway, an inhibitor of the non-mevalonate pathway, or combination of such inhibitors.
• [EN] INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS<br/>[FR] INHIBITION DE VOIES DE BIOSYNTHÈSE D'ISOPRÉNOÏDES POUR TRAITER DES TROUBLES NEURO-INFLAMMATOIRES
  申请人：TABACZYNSKI DAVID A

  公开号：WO2015089349A1

  公开（公告）日：2015-06-18

  This invention provides methods and pharmaceutical compositions that can treat neuroinflammatory disease by reducing the production of pyrophosphate intermediates produced during the biosynthesis of isoprenoids. The pyrophosphate compounds being inhibited are normally produced through the mevalonate and non-mevalonate pathways of the host vertebrate organisms and their symbiotic and pathogenic microorganisms. The methods involve administering to a patient an inhibitor of the mevalonate-dependent pathway, an inhibitor of the non-mevalonate pathway, or combination of such inhibitors.
• Discovery of a New Class of Protein Farnesyltransferase Inhibitors in the Arylthiophene Series
  作者：Sébastien Lethu、Maryon Ginisty、Damien Bosc、Joëlle Dubois

  DOI：10.1021/jm901280q

  日期：2009.10.22

  Screening of the ICSN chemical library led to the discovery of 3-(4-chlorophenyl)-4-cyano-5-thioalkylthiophene 2-carboxylic acids as potent farnesyltransferase inhibitors. Enzymatic kinetic studies showed that this original FTI series belongs to the CaaX competitive inhibitor class. Preliminary SAR studies allowed us to improve the IC50 from 110 to 7.5 nM.

  ICSN化学文库的筛选导致发现3-（4-氯苯基）-4-氰基-5-硫代烷基噻吩2-羧酸作为有效的法呢基转移酶抑制剂。酶动力学研究表明，该原始FTI系列属于CaaX竞争性抑制剂类别。SAR的初步研究使我们能够将IC 50从110 nM提高到7.5 nM。